Fidelity Investments’s SELLAS Life Sciences SLS Stock Holding History

Fidelity Investments’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65.8K	Buy	15,561 +8,066	+108%	+$36.1K	﹤0.01%	3989
2025 Q4	$28.3K	Buy	7,495 +6,467	+629%	+$12.6K	﹤0.01%	4332
2025 Q3	$1.66K	Buy	+1,028	New	+$1.83K	﹤0.01%	4955
2025 Q1	–	Sell	-1	Closed	-$1	–	5648
2024 Q4	$1	Sell	1 -186	-99%	-$212	﹤0.01%	5515
2024 Q3	$233	Buy	+187	New	+$229	﹤0.01%	5025
2024 Q2	–	Sell	-1	Closed	-$1	–	5609
2024 Q1	$1	Buy	+1	New	+$1	﹤0.01%	5335
2021 Q4	–	Sell	-96	Closed	-$1K	–	4874
2021 Q3	$1K	Buy	+96	New	+$891	﹤0.01%	4197

Other funds holding SLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Fidelity Investments's SLS Position: Q1 2026 in Review

Fidelity Investments increased its SELLAS Life Sciences (SLS) stake by 108% in Q1 2026, buying an estimated $36.1K and bringing the position to 15,561 shares worth $65.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3989.

Fidelity Investments first reported a position in SLS in Q3 2021 and has held it in 7 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

Fidelity Investments held 15,561 shares of SELLAS Life Sciences worth $65.8K as of Q1 2026.
Fidelity Investments bought 8,066 SELLAS Life Sciences shares in Q1 2026, an estimated $36.1K.
SELLAS Life Sciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3989 holding.
Fidelity Investments first reported a position in SELLAS Life Sciences in Q3 2021 and has held it in 7 quarters since.
160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.